Sign in
Active, not recruitingNo phase

Efficacy of tDCS in Degenerative Ataxia

Key facts

Who runs it
University of Cagliari
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
16 people enrolled
Started
9 Oct 2023
Ended
Dec 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • transcranial direct current stimulation
  • Sham (No Treatment)
Record updated
26 November 2025

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • clinical, radiological and/or genetic diagnosis of cerebellar ataxia

Who cannot take part

  • presence of electrical stimulators (i.e., pacemaker), pregnancy, visual disfunction, cognitive decline, mild to moderate ataxic symptoms

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Degenerative cerebellar ataxias are a group of rare diseases that cause gradual damage to the cerebellum, the part of the brain that controls balance and coordination. People with these conditions may have difficulty walking, keeping their balance, or coordinating movements. They may also experience vision problems, muscle stiffness, tremors, or changes in behavior, depending on the specific cause of the disease.

Read full original descriptionShow less

These disorders can greatly affect independence and quality of life, and unfortunately, there are currently no treatments that can stop or reverse the disease. Most care focuses on managing symptoms with physical therapy and medication.

Recently, a non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS) has been studied as a possible way to improve movement and thinking in people with ataxia. However, results so far have been mixed, possibly because of differences in disease type, treatment methods, and how improvements are measured.

New technologies, such as motion sensors and movement analysis, are helping researchers better measure the effects of treatments on walking, balance, and hand movements in daily life.

The goal of the current study is to test whether stimulating the cerebellum with anodal tDCS can improve movement in people with different types of degenerative ataxia. The study will use both standard clinical scales and precise movement analysis to measure changes. In addition, researchers will use brain recordings (EEG) taken before and after stimulation to better understand how tDCS may work in the brain

The 2 groups in the trial

  • ShamSham treatment, for comparison

    For sham stimulation the tDCS device delivered just a short ramp of current to let patients feel a skin sensation similar to those perceived by those actually treated.

    Treatment: Sham (No Treatment)

  • RealExisting treatment, for comparison

    Treatment: transcranial direct current stimulation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy of Cerebellar Transcranial Direct Current Stimulation in Degenerative Ataxia. A Sham-controlled Clinical and Quantitative Analysis.
Record updated
26 November 2025